What are the benefits and risks of different corticosteroid treatments delivered intravenously for the prevention of bronchopulmonary dysplasia in infants born prematurely?

The question of whether and how to treat preterm infants with postnatal corticosteroids for the management of bronchopulmonary dysplasia, which is a chronic lung problem due to prematurity, has been a neonatologist ' s quandary for decades. In August 2023, Cochrane Neonatal published a network meta-analysis on the use of postnatal corticosteroids for its prevention. In this podcast, Roger Soll of Cochrane Neonatal, talks with the lead author Susanne Hay, an attending neonatologist at Beth Israel Deaconess Medical Center in the US, about her team ' s work.
Source: Podcasts from The Cochrane Library - Category: General Medicine Authors: Source Type: podcasts